Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The landscape for semaglutide access has shifted, but compounded formulations from licensed 503A pharmacies continue to serve patients seeking weight loss and metabolic support. PlexusDx specializes in precision-compounded semaglutide injections tailored to individual genetic profiles, making this medication accessible and affordable across the United States.
Start a Semaglutide program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded Semaglutide, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
What Happened to Semaglutide Availability and Supply
Semaglutide's popularity for weight loss accelerated dramatically following increased media coverage and clinical success in reducing body weight by 15-22% in landmark trials. This surge in demand initially created supply constraints for brand-name Ozempic and Wegovy, leading many patients to explore compounded alternatives. Licensed 503A compounding pharmacies stepped in to fill gaps by creating pharmaceutical-grade semaglutide injections using FDA-approved active pharmaceutical ingredients.
Unlike brand medications manufactured at scale, compounded semaglutide is prepared by licensed pharmacists in regulated facilities that follow strict quality standards. These pharmacies do not hold FDA approval for compounded drugs themselves—rather, they operate under state pharmacy boards and federal oversight (USP <797> standards). This distinction matters: compounded formulations remain legal, accessible, and frequently more affordable than brand options for eligible patients.
Why Patients Choose Compounded Semaglutide Injections
Compounded semaglutide injections offer flexibility that brand medications sometimes cannot. Patients can adjust dose strength based on individual tolerance and response without waiting for pharmacy stock of pre-filled pens in specific dose increments. PlexusDx compounds semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan with flat pricing — your dose may go up, but your price won't—a pricing model that rewards dose escalation rather than penalizing it.
Access and cost represent major advantages. PlexusDx serves all 50 states, requires no insurance, and charges no membership fees. Medications are HSA and FSA eligible, making them compatible with popular health savings accounts. Patients who previously faced high copays, insurance denials, or brand-name shortages now have a direct alternative that arrives by mail without requiring prior authorization.
How Compounded Semaglutide Differs From Brand-Name Versions
Brand-name semaglutide (Ozempic for diabetes, Wegovy for weight loss) undergoes FDA approval processes that establish safety and efficacy in large clinical populations. Compounded semaglutide uses the same active ingredient but is prepared on-demand by licensed 503A pharmacies using pharmaceutical-grade raw materials. Both contain identical molecular semaglutide; the difference lies in manufacturing location, regulatory pathway, and pricing structure.
Clinical outcomes between compounded and brand semaglutide remain similar when sourced from licensed pharmacies that follow rigorous quality standards. PlexusDx partners exclusively with licensed 503A compounding facilities that verify ingredient purity, sterility, and potency. Patients receive injections with the same mechanism of action—GLP-1 receptor activation—that reduces appetite, slows gastric emptying, and supports sustainable weight loss when combined with lifestyle changes.
Precision Genetic Testing to Optimize Your Semaglutide Response
The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
The genetic test costs $298, providing personalized insights that typically take weeks in a standard clinical trial to discover through trial-and-error dosing. Patients with specific genetic profiles—such as higher GLP1R rs6923761 sensitivity—may achieve results at lower doses, while others with FTO rs9939609 variants benefit from oral formulations paired with behavioral coaching. This precision approach reduces wasted medication and accelerates your path to sustainable weight loss.
Your Semaglutide Options and Cost Comparison at PlexusDx
PlexusDx offers four primary semaglutide pathways: Compounded Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, Oral Semaglutide at $289/mo (or $249/mo on the 6-month plan), Microdose GLP-1 Protocol at $129 per month for milder metabolic support, and GLP-Squared combinations that pair semaglutide with tirzepatide for dual-pathway activation. Your dose may increase over time as your body adapts; PlexusDx pricing remains flat regardless of dose level, meaning no surprise jumps in monthly cost as you titrate upward.
All three membership tiers offer the same medication compounds—the difference is support intensity and genetic testing inclusion. The commitment structure ensures predictable budgeting for weight loss therapy without enrollment fees, insurance hassles, or forced brand-name switches. Patients report saving 40-60% compared to pharmacy cash prices for brand Wegovy, with faster shipping and personalized clinical oversight included at no additional cost.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide still legal and available in 2024?
Yes, compounded semaglutide from licensed 503A pharmacies remains fully legal and widely available across all 50 states. PlexusDx partners with regulated compounding facilities that meet USP <797> standards and state board oversight. The medication uses FDA-approved semaglutide active pharmaceutical ingredients, ensuring pharmaceutical-grade quality without FDA approval of the compounded formulation itself.
How effective is compounded semaglutide for weight loss?
Compounded semaglutide delivers the same active ingredient as brand Wegovy, with clinical studies supporting 15-22% body weight reduction over 68 weeks when combined with lifestyle modifications. PlexusDx patients report an average of 12-18% weight loss within six months, with responses varying based on genetics, adherence, diet, and exercise. Precision Peptide Genetic Testing helps identify your likely response range before you start.
Why does PlexusDx charge a flat monthly price regardless of dose?
PlexusDx uses a flat pricing model—your dose may need to go up, but your price won't—to remove barriers to reaching therapeutic levels. Many patients require dose escalation over weeks or months as their bodies adapt; flat pricing ensures you're not penalized for titrating to your optimal dose. This structure also simplifies budgeting and removes surprise price jumps that deter patients from achieving sustained results.
What side effects should I expect from compounded semaglutide?
Common side effects include mild nausea, constipation, and reduced appetite during the first 2-4 weeks as your body adjusts to GLP-1 activation. Most side effects resolve as you stabilize on your dose; staying hydrated and eating small, protein-rich meals helps. Serious side effects are rare but include pancreatitis and severe dehydration; inform PlexusDx immediately if you experience severe abdominal pain or persistent vomiting.
How does the Precision Peptide Genetic Test help me choose between semaglutide injection and oral?
The test identifies your GLP1R sensitivity, GIPR response, FTO appetite regulation, and MC4R satiety signaling across 14 pathways. Patients with high GLP1R rs6923761 sensitivity often succeed with oral semaglutide at lower cost; those with FTO variants frequently respond better to injection therapy with behavioral support. The $298 test, added after month one, provides personalized guidance that accelerates your weight loss without dose-escalation guesswork.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Quickly Do You Feel the Side Effects of Semaglutide?
Should I Take Tirzepatide in the Morning or Night? Timing Guide